Bioasis Technologies Inc. ( BIOAF) - Key Metrics
BIOAF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2023Q2 | $0 | -$0.01 | $0 | $0 |
| 2023Q1 | $0 | $0 | -$0.01 | -$0.01 |
| 2022Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2022Q3 | $0 | -$0.02 | -$0.01 | -$0.01 |
BIOAF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -3.31 |
| 2023Q2 | 0% | -2.95 |
| 2023Q1 | 0% | -17.30 |
| 2022Q4 | 0% | -8.48 |
| 2022Q3 | 0% | -4.07 |
BIOAF
Price: $0
52 week price:
Earnings Per Share: -0.01 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7941